BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 29374046)

  • 1. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Peters SAE; Muntner P; Woodward M
    Circulation; 2019 Feb; 139(8):1025-1035. PubMed ID: 30779652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
    Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
    Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
    Sun X; Du T
    BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects.
    Kuwabara M; Kuwabara R; Niwa K; Hisatome I; Smits G; Roncal-Jimenez CA; MacLean PS; Yracheta JM; Ohno M; Lanaspa MA; Johnson RJ; Jalal DI
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
    Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.
    Samaranayaka S; Gulliford MC
    Prim Care Diabetes; 2013 Oct; 7(3):193-8. PubMed ID: 23685024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Aging on the Strength of Cardiovascular Risk Factors: A Longitudinal Study Over 40 Years.
    Lind L; Sundström J; Ärnlöv J; Lampa E
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secular trends in cardiovascular disease risk factors according to body mass index in US adults.
    Gregg EW; Cheng YJ; Cadwell BL; Imperatore G; Williams DE; Flegal KM; Narayan KM; Williamson DF
    JAMA; 2005 Apr; 293(15):1868-74. PubMed ID: 15840861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study.
    Xing L; Jing L; Tian Y; Yan H; Zhang B; Sun Q; Dai D; Shi L; Liu D; Yang Z; Liu S
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2262-2270. PubMed ID: 32988725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China.
    Cai L; Liu A; Zhang L; Li S; Wang P
    Clin Exp Hypertens; 2012; 34(1):45-52. PubMed ID: 21967022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.